We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+12.12%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$632M
AUM Growth
+$55.9M
Cap. Flow
+$20M
Cap. Flow %
3.17%
Top 10 Hldgs %
34%
Holding
232
New
81
Increased
31
Reduced
36
Closed
75

Sector Composition

Rank Sector Weight
1 Healthcare 13.24%
2 Real Estate 12.27%
3 Energy 8.36%
4 Utilities 8.29%
5 Consumer Staples 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKS
226
DELISTED
Oneok Partners LP
OKS
-225,000
Closed -$9.01M
HW
227
DELISTED
Headwaters Inc
HW
-70,000
Closed -$1.26M
RTK
228
DELISTED
Rentech, Inc.
RTK
-75,000
Closed -$180K
QGENF
229
DELISTED
QIAGEN NV
QGENF
-10,000
Closed -$218K
STMP
230
DELISTED
Stamps.com, Inc.
STMP
-100,000
Closed -$8.74M
SXE
231
DELISTED
Southcross Energy Partners, L.P.
SXE
-25,000
Closed -$50K
FDC
232
DELISTED
First Data Corporation
FDC
-10,000
Closed -$111K

Similar funds

Ardsley Advisory Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Ardsley Advisory Partners held 232 positions worth $632M, up 9.7% from $576M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ardsley Advisory Partners deployed $20M of net new capital in Q3 2016, opening 81 new positions and adding to 31 existing holdings. Its largest new stake was Alphabet (Google) Class C: 520,000 shares worth $20.2M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $7.14M trimmed.

  • Ardsley Advisory Partners's largest Q3 2016 buy was Alphabet (Google) Class C: 520,000 shares worth $20.2M.
  • Ardsley Advisory Partners added most to TerraForm Global, Inc. Class A Common Stock in Q3 2016, an estimated $10.8M increase.
  • Ardsley Advisory Partners's biggest Q3 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $7.14M.
  • Ardsley Advisory Partners fully exited HCA Healthcare in Q3 2016, selling an estimated $9.97M.
  • Ardsley Advisory Partners's ten largest holdings make up 34% of its $632M portfolio in Q3 2016.
  • Ardsley Advisory Partners opened 81 new positions and closed 75 in Q3 2016.
  • Ardsley Advisory Partners's portfolio value rose 9.7% quarter-over-quarter to $632M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2016, filed 14 Nov 2016.